SAMANTHA WHITEHAWK: Open Payments
NPI 1356952212 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$538 in 25 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $538
Food & beverage: $538
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $98 |
| Novartis Pharmaceuticals Corporation | 3 | $73 |
| PFIZER INC. | 4 | $69 |
| Novo Nordisk Inc | 3 | $65 |
| Alnylam Pharmaceuticals Inc. | 2 | $65 |
| GlaxoSmithKline, LLC. | 2 | $44 |
| AtriCure, Inc. | 1 | $31 |
| Madrigal Pharmaceuticals | 1 | $27 |
| Inspire Medical Systems, Inc. | 1 | $26 |
| ENDOTRONIX, INC. | 1 | $23 |
Products named: REPATHA, LEQVIO, Ozempic, AMVUTTRA, SHINGRIX, ELIQUIS, VYNDAQEL, EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX.
Industry payments across TX — which companies pay providers there.
